Revenues of top diversified products of Bausch Health 2021
This statistic shows the revenues of top U.S. diversified products of Bausch Health in 2021. The revenue of top product Wellbutrin stood at 254 million U.S. dollars in 2021. Bausch Health Companies Inc. was known as Valeant Pharmaceuticals until July 2018 when the name was changed under a new company leadership.